The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes
Abstract Introduction The purpose of this study was to assess prevalence of atherosclerotic cardiovascular disease (ASCVD) according to number of affected vascular beds and the impact on healthcare utilization and costs in persons with type 2 diabetes mellitus (type 2 DM) and established ASCVD. Meth...
Main Authors: | Wayne Weng, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs, Florian M.M. Baeres |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Endocrinology, Diabetes & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1002/edm2.106 |
Similar Items
-
Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting
by: Wayne Weng, et al.
Published: (2020-03-01) -
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States
by: Wayne Weng, et al.
Published: (2019-07-01) -
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk
by: Jose María Mostaza, et al.
Published: (2024-03-01) -
Role of neutrophil-lymphocyte ratio and mean platelet volume in the outcome of atherosclerotic peripheral vascular disease interventions
by: S K Balaji, et al.
Published: (2022-01-01) -
Cerebrovascular Disease Hospitalization Rates in End-Stage Kidney Disease Patients with Kidney Transplant and Peripheral Vascular Disease: Analysis Using the National Inpatient Sample (2005–2019)
by: Tyler John Canova, et al.
Published: (2024-02-01)